ALK Positive Inc. is bringing together patients, care partners, researchers, clinicians, and advocates to help fuel the next frontier in ALK-positive cancer research.

Since the discovery of ALK-positive non-small cell lung cancer in 2007, advances in precision medicine and targeted therapies have dramatically changed the treatment landscape. For many patients, ALK inhibitors have extended survival, improved quality of life, and created treatment possibilities that once seemed out of reach.

But the next frontier of research still lies ahead.

Many patients eventually experience progression and resistance to treatment, leaving them with fewer options and an urgent need for continued innovation. While research has transformed outcomes for the ALK-positive community, durable responses and long-term solutions still depend on continued investment in science, collaboration, and clinical research.

At ALK Positive, we are helping fuel the next generation of research and discovery.

Through community-powered fundraising, research partnerships, support for emerging investigators, and expanded clinical trial opportunities, we are helping fuel the break throughs that bring new hope to patients and families around the world.

Every fundraiser started. Every story shared. Every donation made. Every advocate who raises their voice helps fuel progress toward a cure.

Together, we are fueling the next discovery.

Together, we are fueling the cure.

#FuelTheCure #APAM26